Shares of SAP SE SAP rose sharply in today's pre-market trading after the company reported second-quarter financial results.
SAP reported quarterly earnings of 82 cents per share which missed the analyst consensus estimate of $1.19 per share. Quarterly sales came in at $8.92 billion which missed the analyst consensus estimate of $8.96 billion, representing an 8.81% increase over sales from the same period last year, according to data from Benzinga Pro.
SAP shares gained 5.9% to $212.34 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Nature’s Miracle Holding Inc. NMHI rose 183.4% to $0.9779 in pre-market trading after falling 13% on Monday.
- Volato Group, Inc. SOAR gained 140.5% to $1.15 in pre-market trading after jumping around 20% on Monday.
- Frequency Electronics, Inc. FEIM shares climbed 32% to $13.33 in pre-market trading following fourth-quarter earnings. Also, the company declared a $1.00 special cash dividend.
- MSP Recovery, Inc. LIFW gained 24.6% to $0.6319 in pre-market trading after the company announced a settlement with another group of affiliated P&C insurers.
- Mammoth Energy Services, Inc. TUSK shares gained 23.1% to $4.31 in pre-market trading after the company announced its subsidiary, Cobra Acquisitions, entered into a release and settlement agreement with the Puerto Rico Electric Power Authority.
- MAIA Biotechnology, Inc. MAIA gained 22.9% to $4.61 in pre-market trading after reporting Phase 2 results for lung cancer treatment THIO.
- Professional Diversity Network, Inc. IPDN shares gained 20.2% to $0.59 in pre-market trading.
- New Horizon Aircraft Ltd. HOVR shares gained 13.5% to $0.6105 in pre-market trading after falling over 8% on Monday.
- Mesoblast Limited MESO shares surged 12.5% to $8.50 in pre-market trading. Mesoblast recently started enrollment in Phase 3 trial of Rexlemestrocel-L for chronic low back pain.
Losers
- TransCode Therapeutics, Inc. RNAZ shares fell 57.2% to $0.3395 in pre-market trading. TransCode Therapeutics priced its $3 million public offering of 10 million common shares at $0.30 per share.
- MIRA Pharmaceuticals, Inc. MIRA shares fell 30.3% to $3.49 in pre-market trading. MIRA Pharmaceuticals shares jumped 627% on Monday after the company announced new preclinical study results for its novel oral ketamine analog, Ketamir-2.
- CareMax, Inc. CMAX shares fell 25.3% to $3.87 in pre-market trading after surging 228% on Monday.
- Nukkleus Inc. NUKK shares declined 21.5% to $0.3910 in pre-market trading after gaining over 55% on Monday.
- Exicure, Inc. XCUR shares fell 17.5% to $0.41 in pre-market trading after declining around 7% on Monday.
- Castellum, Inc. CTM fell 15% to $0.17 in pre-market trading. Castellum recently announced a new strategic alliance with Krilla Kaleiwahea.
- Medpace Holdings, Inc. MEDP shares declined 12.6% to $382.00 in pre-market trading after the company reported mixed second-quarter financial results and narrowed its FY24 revenue guidance with its midpoint below estimates.
- Netcapital Inc. NCPL fell 11.8% to $0.0989 in pre-market trading after gaining around 8% on Monday.
- Stem, Inc. STEM shares dipped 11.4% to $1.17 in pre-market trading after gaining 7% on Monday.
- NXP Semiconductors N.V. NXPI shares fell 9.1% to $258.03 in pre-market trading following mixed second-quarter earnings.
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.